R-CHOP regimen

View Patient Information

A regimen consisting of cyclophosphamide, doxorubicin, prednisone, rituximab and vincristine that may be used for the treatment of AIDS-related B-cell lymphomas, Castleman disease, chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, gastric and nongastric MALT lymphomas, nodular lymphocyte-predominant Hodgkin lymphoma, mantle cell Lymphoma, nodal marginal zone lymphoma (NMZL), splenic marginal zone lymphoma (SMZL), Waldenström macroglobulinemia and lymphoplasmacytic lymphoma, and post-transplant lymphoproliferative disorders.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	CHOP-rituximab cyclophosphamide/doxorubicin/prednisone/rituximab/vincristine R-CHOP Rituxan/CHOP rituximab-cyclophosphamide-hydroxydaunorubicin-Oncovin-prednisone regimen rituximab/cyclophosphamide/doxorubicin/prednisone/vincristine
Abbreviation:	CTX/DOX/MOAB IDEC-C2B8/PRED/VCR

R-CHOP regimen

Search NCI's Drug Dictionary